Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Total Current Liabilities (2023 - 2025)

Profound Medical has reported Total Current Liabilities over the past 3 years, most recently at $6.1 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $6.1 million for Q4 2025, down 7.46% from a year ago — trailing twelve months through Dec 2025 was $6.1 million (down 7.46% YoY), and the annual figure for FY2025 was $6.1 million, down 7.46%.
  • Total Current Liabilities for Q4 2025 was $6.1 million at Profound Medical, down from $9.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for PROF hit a ceiling of $9.9 million in Q3 2025 and a floor of $5.3 million in Q1 2025.
  • Median Total Current Liabilities over the past 3 years was $6.2 million (2023), compared with a mean of $6.7 million.
  • Biggest five-year swings in Total Current Liabilities: grew 3.09% in 2024 and later decreased 7.46% in 2025.
  • Profound Medical's Total Current Liabilities stood at $6.4 million in 2023, then increased by 3.09% to $6.6 million in 2024, then dropped by 7.46% to $6.1 million in 2025.
  • The last three reported values for Total Current Liabilities were $6.1 million (Q4 2025), $9.9 million (Q3 2025), and $5.7 million (Q2 2025) per Business Quant data.